Compare COO & RIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | RIVN |
|---|---|---|
| Founded | 1980 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 19.8B |
| IPO Year | N/A | 2021 |
| Metric | COO | RIVN |
|---|---|---|
| Price | $81.36 | $17.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 20 |
| Target Price | ★ $85.82 | $14.79 |
| AVG Volume (30 Days) | 3.3M | ★ 51.1M |
| Earning Date | 12-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.87 | N/A |
| Revenue | $4,092,400,000.00 | ★ $5,835,000,000.00 |
| Revenue This Year | $6.66 | $9.72 |
| Revenue Next Year | $5.54 | $30.31 |
| P/E Ratio | $43.53 | ★ N/A |
| Revenue Growth | 5.06 | ★ 28.21 |
| 52 Week Low | $61.78 | $10.36 |
| 52 Week High | $104.47 | $18.60 |
| Indicator | COO | RIVN |
|---|---|---|
| Relative Strength Index (RSI) | 72.89 | 68.63 |
| Support Level | $75.25 | $16.90 |
| Resistance Level | $78.69 | $17.79 |
| Average True Range (ATR) | 2.48 | 0.85 |
| MACD | 0.47 | 0.21 |
| Stochastic Oscillator | 55.39 | 86.24 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.